Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+121.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+121.3%/yr
vs +4.6%/yr prior
Acceleration
+116.8pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
10.8x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 135.49% |
| 2024 | 7.46% |
| 2023 | 3.12% |
| 2022 | 12.50% |
| 2021 | 14.01% |
| 2020 | -13.25% |
| 2019 | 2.87% |
| 2018 | 10.45% |
| 2017 | -11.42% |
| 2016 | 11.43% |